[
  {
    "ts": null,
    "headline": "Moderna, Inc. (MRNA) Submits Updated COVID Vaccine for Regulatory Review",
    "summary": "Moderna, Inc. (NASDAQ:MRNA) announced on Friday that it has submitted a marketing application to the U.S. Food and Drug Administration (FDA) for review of its updated COVID-19 vaccine. The revised version of the vaccine, marketed as Spikevax, follows FDA guidance recommending that this year’s shots target variants from the JN.1 lineage, specifically favoring the LP.8.1 […]",
    "url": "https://finnhub.io/api/news?id=d4875c14d421fec4129ff45b35d1a66b1e11195ba219bf7681bd16867db00557",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748044428,
      "headline": "Moderna, Inc. (MRNA) Submits Updated COVID Vaccine for Regulatory Review",
      "id": 134686166,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna, Inc. (NASDAQ:MRNA) announced on Friday that it has submitted a marketing application to the U.S. Food and Drug Administration (FDA) for review of its updated COVID-19 vaccine. The revised version of the vaccine, marketed as Spikevax, follows FDA guidance recommending that this year’s shots target variants from the JN.1 lineage, specifically favoring the LP.8.1 […]",
      "url": "https://finnhub.io/api/news?id=d4875c14d421fec4129ff45b35d1a66b1e11195ba219bf7681bd16867db00557"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine",
    "summary": "CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025-2026 formula, targeting the SARS-CoV-2 ...",
    "url": "https://finnhub.io/api/news?id=f79c690f8624e053fdba04c98baedf55724fd2debc9e9144df3653fec2034f29",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748030700,
      "headline": "Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine",
      "id": 134686167,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025-2026 formula, targeting the SARS-CoV-2 ...",
      "url": "https://finnhub.io/api/news?id=f79c690f8624e053fdba04c98baedf55724fd2debc9e9144df3653fec2034f29"
    }
  },
  {
    "ts": null,
    "headline": "Moderna files for review of updated COVID vaccine",
    "summary": "Moderna said on Friday ithas filed a marketing application for the review of its updatedCOVID-19 vaccine with the U.S. Food and Drug Administration. The company said the submission for...",
    "url": "https://finnhub.io/api/news?id=ae50075a994cce491deb38bf539b42152ad3aae96fe7d1e545a0967216803db7",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748019130,
      "headline": "Moderna files for review of updated COVID vaccine",
      "id": 134680361,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Moderna said on Friday ithas filed a marketing application for the review of its updatedCOVID-19 vaccine with the U.S. Food and Drug Administration. The company said the submission for...",
      "url": "https://finnhub.io/api/news?id=ae50075a994cce491deb38bf539b42152ad3aae96fe7d1e545a0967216803db7"
    }
  },
  {
    "ts": null,
    "headline": "Moderna files application for updated COVID vaccine",
    "summary": "Moderna said on Friday it had filed a marketing application for an updated COVID vaccine to the U.S. Food and Drug Administration. The company said the submission is based on guidance...",
    "url": "https://finnhub.io/api/news?id=048675078163d93ffc8078dbc95a1fb3677f28d821665593844d568febe5f5a5",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748017211,
      "headline": "Moderna files application for updated COVID vaccine",
      "id": 134678371,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Moderna said on Friday it had filed a marketing application for an updated COVID vaccine to the U.S. Food and Drug Administration. The company said the submission is based on guidance...",
      "url": "https://finnhub.io/api/news?id=048675078163d93ffc8078dbc95a1fb3677f28d821665593844d568febe5f5a5"
    }
  },
  {
    "ts": null,
    "headline": "The New Covid-19 Jab Policy Wasn’t Up for Debate at the FDA’s Vaccine Meeting. Major Questions Remain.",
    "summary": "The New Covid-19 Jab Policy Wasn’t Up for Debate at the FDA’s Vaccine Meeting. Major Questions Remain.",
    "url": "https://finnhub.io/api/news?id=0b50ea9317de1f7fefa815d65e318f8dc08e0056e95f1cc481e5a364df2fb089",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748006160,
      "headline": "The New Covid-19 Jab Policy Wasn’t Up for Debate at the FDA’s Vaccine Meeting. Major Questions Remain.",
      "id": 134680860,
      "image": "",
      "related": "MRNA",
      "source": "MarketWatch",
      "summary": "The New Covid-19 Jab Policy Wasn’t Up for Debate at the FDA’s Vaccine Meeting. Major Questions Remain.",
      "url": "https://finnhub.io/api/news?id=0b50ea9317de1f7fefa815d65e318f8dc08e0056e95f1cc481e5a364df2fb089"
    }
  }
]